RenovoRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RenovoRx and other ETFs, options, and stocks.About RNXT
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors.
CEOShaun R. Bagai
CEOShaun R. Bagai
Employees10
Employees10
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded2009
Founded2009
Employees10
Employees10
RNXT Key Statistics
Market cap34.38M
Market cap34.38M
Price-Earnings ratio-2.67
Price-Earnings ratio-2.67
Dividend yield—
Dividend yield—
Average volume225.80K
Average volume225.80K
High today$0.9698
High today$0.9698
Low today$0.9261
Low today$0.9261
Open price$0.95
Open price$0.95
Volume97.87K
Volume97.87K
52 Week high$1.69
52 Week high$1.69
52 Week low$0.7006
52 Week low$0.7006
Stock Snapshot
As of today, RenovoRx(RNXT) shares are valued at $0.94. The company's market cap stands at 34.38M, with a P/E ratio of -2.67.
On 2025-12-05, RenovoRx(RNXT) stock traded between a low of $0.93 and a high of $0.97. Shares are currently priced at $0.94, which is +1.3% above the low and -3.3% below the high.
The RenovoRx(RNXT)'s current trading volume is 97.87K, compared to an average daily volume of 225.8K.
During the past year, RenovoRx(RNXT) stock moved between $0.70 at its lowest and $1.69 at its peak.
During the past year, RenovoRx(RNXT) stock moved between $0.70 at its lowest and $1.69 at its peak.
People also own
Based on the portfolios of people who own RNXT. This list is generated using Robinhood data, and it’s not a recommendation.